论文部分内容阅读
目的:探讨合并糖尿病的终末期肾病患者接受死亡后器官捐献(DD)供者供肾移植的近期效果。方法:回顾性分析西安交通大学第一附属医院肾移植科70例肾移植的临床资料，根据受者肾移植前是否合并糖尿病将受者分为糖尿病组和对照组。比较两组受者免疫抑制方案、移植肾功能及血糖的变化。比较两组术后移植肾功能恢复延迟(DGF)、急性排斥反应(AR)、不良反应发生率以及受者和移植肾术后1年的存活情况。结果:两组受者肾移植术后DGF、AR、感染发生率及移植肾功能的差异均无统计学意义(n P>0.05)。两组间术后1年受者和移植肾的存活率的差异均无统计学意义(n P>0.05)。糖尿病组受者术后住院时间、使用环孢素A的受者比例，伤口愈合不良和排尿困难发生率，以及术后1年内血糖水平均显著高于对照组，差异均有统计学意义(n P0.05). No statistically significant inter-group difference existed in recipient or renal graft survival (n P>0.05). Length of hospital stay, proportion of cyclosporin, postoperative poor wound healing, incidence of dysuria and blood glucose level within 1 year post-transplantation were significantly higher in diabetic group than those in control group (n P<0.05).n Conclusions:End-stage renal disease diabetics often develop the complications of poor wound healing and dysuria. And blood glucose is still higher than that of non-diabetics after renal transplantation from DD donors. However, there was no difference of outcome at Year 1 post-transplantation between diabetics and non-diabetics.